Tirzepatide Forte Flex-Dose 4 mL

Tirzepatide Flex-Dose 60 mg vial is a prescriber- and patient-driven compound designed to allow fully customizable dosing based on the provider’s clinical judgment. It is administered subcutaneously and supports flexible dosing frequencies, including micro-dosing, multiple weekly injections, or a once-weekly flex titration schedule.

Directions

Directions MUST be prescribed in UNITS.

• • • Example: Inject 10 units on insulin syringe subcutaneously twice weekly.

Clinical Reason Statement

A Clinical Reason Statement is required when prescribing Tirzepatide. If a Clinical Difference Statement is not provided, the prescription will be cancelled and the patient will be referred to the commercially available product, if available.

To ensure proper submission, please follow the instructions below:

• • • LifeFile eRx Portal: Enter the clinical reason in the “Clinical Statement” field when submitting your order.
    • API Integrations: A new Clinical Statement field is now available for practices sending prescriptions through integrated systems.
    • Faxed Prescriptions: The clinical reason must be clearly written out on the prescription itself.